アラバマ州における大腸癌の臨床試験
アラバマ州内の拠点で、大腸癌に関する12件の研究が参加者を募集しています。
アラバマ州内の都市
公式研究テキスト（英語）
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
- UAB O'Neal Comprehensive Cancer Center - The Kirklin Clinic of UAB Hospital, Birmingham
被験者募集中第2相
18歳以上 · 全性別 · 2026/10/02更新 · NCT06760819177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors
- Dothan Hematology & Oncology, Dothan
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/10/01更新 · NCT07189871PRE-ISPY Phase I/II Oncology Platform Program
- The University of Alabama at Birmingham O'Neal Comprehensive Cancer Center, Birmingham
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/30更新 · NCT05868226A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
- Mitchell Cancer Institute, Mobile
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/15更新 · NCT07284849Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
- Clinical Study Site, Mobile
- Clinical Study Site, Tuscaloosa
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/08更新 · NCT07228832Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- Children's Hospital of Alabama, Birmingham
被験者募集中第1/2相
12 Months – 30 Years · 全性別 · 2026/08/25更新 · NCT04851119A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
- University of Alabama at Birmingham, Birmingham
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/07/30更新 · NCT04657068Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
- Uni of Alabama at Birmingham, Birmingham
被験者募集中第1相
18歳〜100歳 · 全性別 · 2026/07/29更新 · NCT06562192Initial Testing of a Behavioral Intervention About Genetic Services for Families at Risk of Lynch Syndrome
- UAB, Birmingham
被験者募集中健康なボランティア歓迎
18歳以上 · 全性別 · 2026/07/21更新 · NCT07106359A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
- Clearview Cancer Institute - Huntsville - Cci Drive /ID# 278621, Huntsville
被験者募集中第2相
18歳以上 · 全性別 · 2026/07/10更新 · NCT07023289A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer
- Central Alabama Research, Birmingham
- University of Alabama at Birmingham, Birmingham
被験者募集中第4相
18歳以上 · 全性別 · 2026/07/07更新 · NCT06562543Time-Restricted Eating and Cancer: Clinical Outcomes, Mechanisms, and Moderators
- The University of Alabama at Birmingham, Birmingham
被験者募集中
18歳以上 · 全性別 · 2025/12/16更新 · NCT04722341ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。